PERCEPTIVE ADVISORS LLC Q4 2019 Filing

Filed February 14, 2020

Portfolio Value

$6.2B

Holdings

114

Report Date

Q4 2019

Filing Type

13F-HR

All Holdings (114 positions)

#StockSharesValue% PortfolioType
101
ZYNERBA PHARMACEUTICALS INC
200,000$790.0M12.75%Put
102
MREOMEREO BIOPHARMA GROUP PLC
179,419$588.0M9.49%
103
OPTINOSE INC
58,005$535.0M8.64%
104
KRTXKARUNA THERAPEUTICS INC
6,944$523.0M8.44%
105
NTRANATERA INC
14,549$490.0M7.91%
106
KRMDREPRO MED SYS INC
74,813$489.0M7.89%
107
ACADACADIA PHARMACEUTICALS INC
11,256$482.0M7.78%
108
VSAREURARAVIVE INC
32,895$450.0M7.26%
109
CONSTELLATION PHARMCETICLS INC
6,000$283.0M4.57%
110
PROTEON THERAPEUTICS INC
341,743$140.0M2.26%
111
AVDLAVADEL PHARMACEUTICALS PLC
8,681$66.0M1.07%
112
OUTLOOK THERAPEUTICS INC
420,875$33.0M0.53%
113
RESTORBIO INC
9,306$14.0M0.23%
114
ONCBEIGENE LTD
200,000$4.0M0.06%Put
PreviousPage 2 of 2